Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation

American Journal of Cardiology

Volumn 93, Issue 2, 2004, Pages 247-250

  Fanikos, John ^a   Tsilimingras, Kanella ^a   Kucher, Nils ^a   Rosen, Allison B ^a   Hieblinger, Melissa D ^a   Goldhaber, Samuel Z ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; AORTA VALVE PROSTHESIS; ARTICLE; BLEEDING TENDENCY; CONGESTIVE HEART FAILURE; CONTINUOUS INFUSION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART ATRIUM FIBRILLATION; HEART DEATH; HOSPITAL COST; HOSPITAL PATIENT; HUMAN; INTERMETHOD COMPARISON; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; PERICARDIAL EFFUSION; PERITONITIS; PLEURA EFFUSION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; STROKE; THROMBOCYTOPENIA; THROMBOEMBOLISM; VISUAL DISORDER;

EID: 0347593909     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2003.09.054     Document Type: Article

References (11)

1. Montelescot G., Polle V., Collet J.P., Leprince P., Bellanger A., Gandjbakhch I., Thomas D. Low molecular weight heparin after mechanical heart valve replacement. Circulation. 101:2000;1083-1086.
2. Spandorfer J.M., Lynch S., Weitz H.H., Fertel S., Merli G.J. Use of enoxaparin for the chronically anticoagulated patient before and after procedures. Am J Cardiol. 84:1999;478-480.
3. Tinmouth A.H., Morrow B.H., Cruickshank M.K., Moore P.M., Kovacs M.J. Dalteparin as periprocedure anticoagulation for patients on warfarin and at high risk of thrombosis. Ann Pharmacother. 35:2001;669-674.
4. Topol EJ, Bosker G, Casele H, Elkayam U, Goldhaber SZ, Grimm R, Groce JB III, Heit JA, James A, Klein A, et al. Anticoagulation and enoxaparin use in patients with prosthetic heart valves and/or pregnancy. Clin Cardio Consens Rep 2002; 3:1-19.
5. Levine M., Gent M., Hirsh J., Leclerc J., Anderson D., Weitz J., Ginsberg J., Turpie A.G., Demers C., Kovacs M., et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med. 334:1996;677-681.
6. Koopman M.M., Prandoni P., Piovella F., Ockelford P.A., Brandjes D.P.M., van der Meer J., Gallus A.S., Simonneau G., Chesterman C.H., Prins M.H., et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low- molecular-weight heparin administered at home. The Tasman Study Group. N Engl J Med. 334:1996;682-687.
7. Gould M.K., Dembitzer A.D., Doyle R.L., Hastie T.J., Garber A.M. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. Ann Intern Med. 130:1999;800-809.
8. O'Brien B., Levine M., Willan A., Goeree R., Haley S., Blackhouse G., Gent M. Economic evaluation of outpatient treatment with low-molecular-weight heparin for proximal vein thrombosis. Arch Intern Med. 159:1999;2298-2304.
9. Gould M.K., Dembitzer A.D., Sanders G.D., Garber A.M. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis. Ann Intern Med. 130:1999;789-799.
10. Ansell J., Hirsh J., Dalen J., Bussey H., Anderson D., Poller L., Jacobson A., Deykin D., Matchar D. Managing oral anticoagulant therapy. Chest. 119:(suppl 1):2001;22S-38S.
11. Bonow R.O., Carabello B., de Leon A.C., Edmunds L.H., Fedderly B.J., Freed M.D., Gaasch W.H., McKay C.R., Nishimura R.A., O'Gara P.T., et al. Guidelines for the management of patients with valvular heart disease executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease) . Circulation. 98:1998;1949-1984.